Literature DB >> 23015293

Examination of ERα signaling pathways in bone of mutant mouse models reveals the importance of ERE-dependent signaling.

Kumar Chokalingam1, Matthew M Roforth, Kristy M Nicks, Ulrike McGregor, Daniel Fraser, Sundeep Khosla, David G Monroe.   

Abstract

The mechanisms of estrogen receptor (ER)-α activity can be categorized into those involving direct (classical) or indirect (nonclassical) DNA binding. Although various mouse models have demonstrated the importance of ERα in bone, the specific gene expression patterns affected by these modes of ERα action are unknown. In this report, the gene expression patterns of ERα-deficient (ERKO) mice and nonclassical ER knock-in (NERKI) mice, which can function only by nonclassical means, were analyzed. Three-month-old mice were ovariectomized and implanted with estrogen pellets for 1 month to normalize estrogen levels. Microarray analysis of flushed cortical bone revealed 28% (210 of 763) of the genes differentially expressed in ERKO mice were altered in NERKI mice, suggesting estrogen response element-dependent regulation of these genes in bone. Pathway analysis revealed alterations in genes involved in focal adhesion and extracellular matrix interactions. However, the majority of genes regulated in ERKO mice (72%) were unique (i.e. not altered in NERKI mice), suggesting these are regulated by nonclassical mechanisms. To further explore the pathways affected in ERKO mice, we performed focused quantitative PCR arrays for genes involved in various aspects of bone physiology. Genes involved in bone formation, senescence, apoptosis, and autophagy were significantly regulated. Overall, the majority of the genes regulated by ERα in bone are via nonclassical pathways. However, because NERKI mice display an osteoporotic phenotype, it can be deduced that the minority of the estrogen response element-dependent genes/pathways play critical roles in the regulation of bone physiology. These data demonstrate the importance of classical ERα signaling in regulating bone metabolism.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23015293      PMCID: PMC3473212          DOI: 10.1210/en.2012-1721

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  34 in total

1.  Deletion of estrogen receptors reveals a regulatory role for estrogen receptors-beta in bone remodeling in females but not in males.

Authors:  N A Sims; S Dupont; A Krust; P Clement-Lacroix; D Minet; M Resche-Rigon; M Gaillard-Kelly; R Baron
Journal:  Bone       Date:  2002-01       Impact factor: 4.398

2.  Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway.

Authors:  M Jakacka; M Ito; J Weiss; P Y Chien; B D Gehm; J L Jameson
Journal:  J Biol Chem       Date:  2001-01-18       Impact factor: 5.157

Review 3.  Estrogen and the skeleton.

Authors:  Sundeep Khosla; Merry Jo Oursler; David G Monroe
Journal:  Trends Endocrinol Metab       Date:  2012-05-16       Impact factor: 12.015

4.  Identification of a new isoform of the human estrogen receptor-alpha (hER-alpha) that is encoded by distinct transcripts and that is able to repress hER-alpha activation function 1.

Authors:  G Flouriot; H Brand; S Denger; R Metivier; M Kos; G Reid; V Sonntag-Buck; F Gannon
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

5.  Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow.

Authors:  T Masuzawa; C Miyaura; Y Onoe; K Kusano; H Ohta; S Nozawa; T Suda
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

6.  Dose-response of estrogen on bone versus the uterus in ovariectomized mice.

Authors:  Ulrike I L Modder; B Lawrence Riggs; Thomas C Spelsberg; Daniel G Fraser; Elizabeth J Atkinson; Rudolf Arnold; Sundeep Khosla
Journal:  Eur J Endocrinol       Date:  2004-10       Impact factor: 6.664

7.  An estrogen receptor (ER)alpha deoxyribonucleic acid-binding domain knock-in mutation provides evidence for nonclassical ER pathway signaling in vivo.

Authors:  Monika Jakacka; Masafumi Ito; Fred Martinson; Toshio Ishikawa; Eun Jig Lee; J Larry Jameson
Journal:  Mol Endocrinol       Date:  2002-10

8.  Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis.

Authors:  B Adams; P Dörfler; A Aguzzi; Z Kozmik; P Urbánek; I Maurer-Fogy; M Busslinger
Journal:  Genes Dev       Date:  1992-09       Impact factor: 11.361

9.  Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene.

Authors:  D B Lubahn; J S Moyer; T S Golding; J F Couse; K S Korach; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

10.  Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes.

Authors:  S Dupont; A Krust; A Gansmuller; A Dierich; P Chambon; M Mark
Journal:  Development       Date:  2000-10       Impact factor: 6.868

View more
  11 in total

1.  Identification of Rorβ targets in cultured osteoblasts and in human bone.

Authors:  Matthew M Roforth; Sundeep Khosla; David G Monroe
Journal:  Biochem Biophys Res Commun       Date:  2013-10-11       Impact factor: 3.575

2.  β-Ecdysone Augments Peak Bone Mass in Mice of Both Sexes.

Authors:  Weiwei Dai; HongLiang Zhang; Zhendong A Zhong; Li Jiang; Haiyan Chen; Yu-An Evan Lay; Alexander Kot; Robert O Ritchie; Nancy E Lane; Wei Yao
Journal:  Clin Orthop Relat Res       Date:  2015-08       Impact factor: 4.176

Review 3.  27-Hydroxycholesterol, an endogenous selective estrogen receptor modulator.

Authors:  Sisi He; Erik R Nelson
Journal:  Maturitas       Date:  2017-07-31       Impact factor: 4.342

Review 4.  The molecular mechanisms underlying the pharmacological actions of estrogens, SERMs and oxysterols: implications for the treatment and prevention of osteoporosis.

Authors:  Erik R Nelson; Suzanne E Wardell; Donald P McDonnell
Journal:  Bone       Date:  2012-11-17       Impact factor: 4.398

5.  Novel DNA motif binding activity observed in vivo with an estrogen receptor α mutant mouse.

Authors:  Sylvia C Hewitt; Leping Li; Sara A Grimm; Wipawee Winuthayanon; Katherine J Hamilton; Brianna Pockette; Cory A Rubel; Lars C Pedersen; David Fargo; Rainer B Lanz; Francesco J DeMayo; Günther Schütz; Kenneth S Korach
Journal:  Mol Endocrinol       Date:  2014-04-08

Review 6.  Estrogen synthesis and signaling pathways during aging: from periphery to brain.

Authors:  Jie Cui; Yong Shen; Rena Li
Journal:  Trends Mol Med       Date:  2013-01-22       Impact factor: 11.951

7.  Improved Mobilization of Exogenous Mesenchymal Stem Cells to Bone for Fracture Healing and Sex Difference.

Authors:  Wei Yao; Yu-An Evan Lay; Alexander Kot; Ruiwu Liu; Hongliang Zhang; Haiyan Chen; Kit Lam; Nancy E Lane
Journal:  Stem Cells       Date:  2016-07-15       Impact factor: 6.277

8.  Deletion of Estrogen Receptor Beta in Osteoprogenitor Cells Increases Trabecular but Not Cortical Bone Mass in Female Mice.

Authors:  Kristy M Nicks; Koji Fujita; Daniel Fraser; Ulrike McGregor; Matthew T Drake; Meghan E McGee-Lawrence; Jennifer J Westendorf; David G Monroe; Sundeep Khosla
Journal:  J Bone Miner Res       Date:  2015-10-13       Impact factor: 6.741

Review 9.  Sex steroid actions in male bone.

Authors:  Dirk Vanderschueren; Michaël R Laurent; Frank Claessens; Evelien Gielen; Marie K Lagerquist; Liesbeth Vandenput; Anna E Börjesson; Claes Ohlsson
Journal:  Endocr Rev       Date:  2014-09-09       Impact factor: 19.871

10.  Requirement of estrogen receptor alpha DNA-binding domain for HPV oncogene-induced cervical carcinogenesis in mice.

Authors:  Jieun Son; Jung Wook Park; Paul F Lambert; Sang-Hyuk Chung
Journal:  Carcinogenesis       Date:  2013-10-22       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.